Evidence map›Paper›PMID 39365439›Full record

ArticleTAG. Theoretical and applied genetics. Theoretische und angewandte Genetik2024

Integrating targeted genetic markers to genotyping-by-sequencing for an ultimate genotyping tool.

Maxime de Ronne, Amina Abed, Gaétan Légaré, Jérôme Laroche, Vincent-Thomas Boucher St-Amour, Éric Fortier, Aaron Beattie, Ana Badea, Raja Khanal, Louise O'Donoughue and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maxime de RonneDépartement de Phytologie, Université Laval, Québec, Canada.
Amina AbedConsortium de Recherche Sur La Pomme de Terre du Québec (CRPTQ), Québec, Canada.
Gaétan LégaréInstitut de Biologie Intégrative Et Des Systèmes (IBIS), Université Laval, Québec, Canada.
Jérôme LarocheInstitut de Biologie Intégrative Et Des Systèmes (IBIS), Université Laval, Québec, Canada.
Vincent-Thomas Boucher St-AmourDépartement de Phytologie, Université Laval, Québec, Canada.
Éric FortierCentre de Recherche Sur Les Grains (CÉROM), Saint-Mathieu-de-Beloeil, Québec, Canada.
Aaron BeattieDepartment of Plant Sciences, University of Saskatchewan, Saskatoon, Canada.
Ana BadeaAgriculture and Agri-Food Canada, Brandon Research and Development Centre, Brandon, Canada.
Raja KhanalAgriculture and Agri-Food Canada, Ottawa Research and Development Center, Ottawa, Canada.
Louise O'DonoughueCentre de Recherche Sur Les Grains (CÉROM), Saint-Mathieu-de-Beloeil, Québec, Canada.
Istvan RajcanDepartment of Plant Agriculture, University of Guelph, Guelph, Canada.
François BelzileDépartement de Phytologie, Université Laval, Québec, Canada.
Brian BoyleInstitut de Biologie Intégrative Et Des Systèmes (IBIS), Université Laval, Québec, Canada.
Davoud TorkamanehDépartement de Phytologie, Université Laval, Québec, Canada. davoud.torkamaneh.1@ulaval.ca.ORCID http://orcid.org/0000-0002-9782-5695

Funding

Genome Canada #6548
6 · The paper itself

Abstract

New selection methods, using trait-specific markers (marker-assisted selection (MAS)) and/or genome-wide markers (genomic selection (GS)), are becoming increasingly widespread in breeding programs. This new era requires innovative and cost-efficient solutions for genotyping. Reduction in sequencing cost has enhanced the use of high-throughput low-cost genotyping methods such as genotyping-by-sequencing (GBS) for genome-wide single-nucleotide polymorphism (SNP) profiling in large breeding populations. However, the major weakness of GBS methodologies is their inability to genotype targeted markers. Conversely, targeted methods, such as amplicon sequencing (AmpSeq), often face cost constraints, hindering genome-wide genotyping across a large cohort. Although GBS and AmpSeq data can be generated from the same sample, an efficient method to achieve this is lacking. In this study, we present the Genome-wide & Targeted Amplicon (GTA) genotyping platform, an innovative way to integrate multiplex targeted amplicons into the GBS library preparation to provide an all-in-one cost-effective genotyping solution to breeders and research communities. Custom primers were designed to target 23 and 36 high-value markers associated with key agronomical traits in soybean and barley, respectively. The resulting multiplex amplicons were compatible with the GBS library preparation enabling both GBS and targeted genotyping data to be produced efficiently and cost-effectively. To facilitate data analysis, we have introduced Fast-GBS.v3, a user-friendly bioinformatic pipeline that generates comprehensive outputs from data obtained following sequencing of GTA libraries. This high-throughput low-cost approach will greatly facilitate the application of DNA markers as it provides required markers for both MAS and GS in a single assay.

Indexed as

Genotyping TechniquesGlycine maxPolymorphism, Single NucleotideGenetic MarkersGenotypeHigh-Throughput Nucleotide SequencingHordeumPlant BreedingSequence Analysis, DNAGenetic MarkersAmplicon sequencing (AmpSeq)Genome wide and targeted genotypingGenomic selectionGenotyping By sequencing (GBS)High throughputMarker-assisted selectionSingle nucleotide polymorphism

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.